Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin

Pax8 Detection in Well-Differentiated Pancreatic Endocrine Tumors

(2011) Carmen M. Jimenez Moreno et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Future Directions in the Treatment of Neuroendocrine Tumors: Consensus Report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting

(2011) Matthew H. Kulke et al.   JOURNAL OF CLINICAL ONCOLOGY

Primary Extragastrointestinal Stromal Tumor of the Pleura: Report of a Unique Case With Genetic Confirmation

(2010) Kevin B. Long et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma

(2010) Ankur R Sangoi et al.   MODERN PATHOLOGY

Islet 1 (Isl1) Expression is a Reliable Marker for Pancreatic Endocrine Tumors and Their Metastases

(2009) Anja M. Schmitt et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Immunohistochemical Staining for CDX-2, PDX-1, NESP-55, and TTF-1 Can Help Distinguish Gastrointestinal Carcinoid Tumors From Pancreatic Endocrine and Pulmonary Carcinoid Tumors

(2009) Amitabh Srivastava et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

(2008) James C. Yao et al.   JOURNAL OF CLINICAL ONCOLOGY

Gastroenteropancreatic neuroendocrine tumours

(2008) Irvin M Modlin et al.   LANCET ONCOLOGY